ArticleIn vivo (Athens, Greece)

Cancer-induced Pain Is Associated With Poor Overall Survival of Urothelial Carcinoma Patients Treated With Enfortumab Vedotin.

Mamoru Hashimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.